의학적 장애의 치료를 위한 시클린-의존성 키나제 억제 화합물

본 발명은 비정상적 세포 증식을 수반하는 장애의 치료를 위한 세포 주기 억제 화합물 분야에 속하며, 의료 요법을 위한 선택적 CDK2 억제제 및 그의 제약상 허용되는 염 및 조성물을 포함한다. This invention is in the area of cell cycle inhibiting compounds for the treatment of disorders involving abnormal cellular proliferation, and include selective CDK2 inhibitors for medical the...

Full description

Saved in:
Bibliographic Details
Main Author STRUM JAY COPELAND
Format Patent
LanguageKorean
Published 26.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 본 발명은 비정상적 세포 증식을 수반하는 장애의 치료를 위한 세포 주기 억제 화합물 분야에 속하며, 의료 요법을 위한 선택적 CDK2 억제제 및 그의 제약상 허용되는 염 및 조성물을 포함한다. This invention is in the area of cell cycle inhibiting compounds for the treatment of disorders involving abnormal cellular proliferation, and include selective CDK2 inhibitors for medical therapy and their pharmaceutically acceptable salts and compositions.
AbstractList 본 발명은 비정상적 세포 증식을 수반하는 장애의 치료를 위한 세포 주기 억제 화합물 분야에 속하며, 의료 요법을 위한 선택적 CDK2 억제제 및 그의 제약상 허용되는 염 및 조성물을 포함한다. This invention is in the area of cell cycle inhibiting compounds for the treatment of disorders involving abnormal cellular proliferation, and include selective CDK2 inhibitors for medical therapy and their pharmaceutically acceptable salts and compositions.
Author STRUM JAY COPELAND
Author_xml – fullname: STRUM JAY COPELAND
BookMark eNrjYmDJy89L5WQIfjN3xtupM98saFR4M2_pm6kLgHyFNztnvF7c83rpHoU3c1reTp2j8KZ7ztvGLa-XbdAFSr9ZuOVNy0aFt01LXjfNeLMAKDttK4h6O3PK26krX6_Zw8PAmpaYU5zKC6W5GZTdXEOcPXRTC_LjU4sLEpNT81JL4r2DjAyMjA0MDI1MTcwdjYlTBQDLdlKM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20230012547A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20230012547A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:01:04 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20230012547A3
Notes Application Number: KR20227043846
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230126&DB=EPODOC&CC=KR&NR=20230012547A
ParticipantIDs epo_espacenet_KR20230012547A
PublicationCentury 2000
PublicationDate 20230126
PublicationDateYYYYMMDD 2023-01-26
PublicationDate_xml – month: 01
  year: 2023
  text: 20230126
  day: 26
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies G1 THERAPEUTICS, INC
RelatedCompanies_xml – name: G1 THERAPEUTICS, INC
Score 3.4105484
Snippet 본 발명은 비정상적 세포 증식을 수반하는 장애의 치료를 위한 세포 주기 억제 화합물 분야에 속하며, 의료 요법을 위한 선택적 CDK2 억제제 및 그의 제약상 허용되는 염 및 조성물을 포함한다. This invention is in the area of cell cycle...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 의학적 장애의 치료를 위한 시클린-의존성 키나제 억제 화합물
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230126&DB=EPODOC&locale=&CC=KR&NR=20230012547A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUwzSwRCU11gZW2iC6yvDXWBrXoDXRMzI9AxuCbAVipov7Ovn5lHqIlXhGkEE0MObC8M-JzQcvDhiMAclQzM7yXg8roAMYjlAl5bWayflAkUyrd3C7F1UYP2joHtaUMjMzUXJ1vXAH8Xf2c1Z2db7yA1vyCIHFDS1MTckZmBFdSQBp207xrmBNqXUoBcqbgJMrAFAM3LKxFiYMrOF2bgdIbdvSbMwOELnfIGMqG5r1iEIfjN3Blvp858s6BR4c28pW-mLgDyFd7snPF6cc_rpXsU3sxpeTt1jsKb7jlvG7e8XrZBFyj9ZuGWNy0bFd42LXndNOPNAqDstK0g6u3MKW-nrny9Zo8og7Kba4izhy7QdfHwwIj3DkL2irEYA0tefl6qBINCqrEB-Kx3C8s0Y5M0C8NEk0TzRHOTxCQLC1NzY5NESQYZfCZJ4ZeWZuACcUGDD0ZmMgwsJUWlqbLA6rgkSQ4cigCQXqRt
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUwzSwRCU11gZW2iC6yvDXWBrXoDXRMzI9AxuCbAVipov7Ovn5lHqIlXhGkEE0MObC8M-JzQcvDhiMAclQzM7yXg8roAMYjlAl5bWayflAkUyrd3C7F1UYP2joHtaUMjMzUXJ1vXAH8Xf2c1Z2db7yA1vyCIHFDS1MTckZmB1Rx0Pi-o8RTmBNqXUoBcqbgJMrAFAM3LKxFiYMrOF2bgdIbdvSbMwOELnfIGMqG5r1iEIfjN3Blvp858s6BR4c28pW-mLgDyFd7snPF6cc_rpXsU3sxpeTt1jsKb7jlvG7e8XrZBFyj9ZuGWNy0bFd42LXndNOPNAqDstK0g6u3MKW-nrny9Zo8og7Kba4izhy7QdfHwwIj3DkL2irEYA0tefl6qBINCqrEB-Kx3C8s0Y5M0C8NEk0TzRHOTxCQLC1NzY5NESQYZfCZJ4ZeWZ-D0CPH1iffx9POWZuACSYEGIozMZBhYSopKU2WBVXNJkhw4RAFq2ada
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%EC%9D%98%ED%95%99%EC%A0%81+%EC%9E%A5%EC%95%A0%EC%9D%98+%EC%B9%98%EB%A3%8C%EB%A5%BC+%EC%9C%84%ED%95%9C+%EC%8B%9C%ED%81%B4%EB%A6%B0-%EC%9D%98%EC%A1%B4%EC%84%B1+%ED%82%A4%EB%82%98%EC%A0%9C+%EC%96%B5%EC%A0%9C+%ED%99%94%ED%95%A9%EB%AC%BC&rft.inventor=STRUM+JAY+COPELAND&rft.date=2023-01-26&rft.externalDBID=A&rft.externalDocID=KR20230012547A